Zachary T Freeman Selected Research

Interleukin-3 (Interleukin 3)

1/2021

Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zachary T Freeman Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 12/2016
1	Hemolysis 01/2024
1	Inflammation (Inflammations) 12/2021
1	Leukemia 01/2021
1	Endometrioid Carcinoma 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 10/2019
1	Weight Loss (Weight Reduction) 01/2019

Drug/Important Bio-Agent (IBA)

1	Complement System Proteins (Complement)IBA 01/2024
1	compstatinIBA 01/2024
1	Interleukin-6 (Interleukin 6)IBA 12/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021
1	Stem Cell FactorIBA 01/2021
1	Interleukin-3 (Interleukin 3)IBA 01/2021
1	B7-H1 AntigenIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 10/2019
1	ZD4054IBA 01/2019
1	Endothelin A ReceptorIBA 01/2019
1	AntigensIBA 12/2016
1	CytokinesIBA 12/2016

Therapy/Procedure

2	Immunotherapy 01/2020 - 10/2019
1	Transplantation 01/2021
1	Therapeutics 10/2019